Onyx Pharmaceuticals, Inc.
California, USA Onyx Pharmaceuticals, Inc. develops small molecule cancer treatments based on a molecular understanding of cancer. Our products include NexavarŽ (sorafenib) tablets, a novel, oral multiple kinase inhibitor that targets proteins involved in both tumor cell proliferation and angiogenesis. Our NexavarŽ More...
www.onyx-pharm.com

 Otava
Ukraine, Ukraine Kinase, inhibitor, docking, focused library, targeted library, active compounds, biological activity, screening, lead discovery, drug development, inhibitor, Death-Associated Protein Kinase 2,DAPK-2, p38 MAP Kinase Alpha, Vascular Endothelial Growth Factor Receptor 2, VEGFR2, Aurora B kinase, Janus Kinase 2, Jak2, Phosphatidylinositol 3-kinase, PI3K, 3-phosphoinositide-dependent kinase-1, 3-phosph More...
www.otavachemicals.com | SEND INQUIRY